Arcing toward AI

British partnership using AI for early drug discovery

LifeArc announced in January it is tapping into AI capabilities at the University of Cambridge’s Milner Therapeutics Institute through a partnership aimed at identifying and validating new targets for cancer immunotherapy and respiratory disease early in the drug discovery process.


Read the full 405 word article

User Sign In